David Ames
Impact in
- Psychiatry and Mental health top 0.05%
- Dementia and Cognitive Impairment Research
- Physiology top 0.1%
- Alzheimer's disease research and treatments
Papers in
-
- Dementia and Cognitive Impairment Research 190
- Schizophrenia research and treatment 15
- Physiology 77
- Alzheimer's disease research and treatments 66
- Co-authors
- Colin L. Masters (188 shared papers)Ralph N. Martins (148 shared papers)Victor L. Villemagne (132 shared papers)Kathryn A. Ellis (112 shared papers)Paul Maruff (108 shared papers)Cassandra Szoeke (63 shared papers)Christopher C. Rowe (99 shared papers)Olivier Salvado (68 shared papers)
- Journals
- Alzheimer s & Dementia (40 papers)International Journal of Geriatric Psychiatry (38 papers)Journal of Alzheimer s Disease (34 papers)International Psychogeriatrics (25 papers)The Medical Journal of Australia (8 papers)
- Partner nations
- AustraliaUnited StatesUnited Kingdom
In The Last Decade
David Ames
384 papers receiving 18.1k citations
David Ames's Hit Papers
Peers
Comparison fields: 5 of 203
- Psychiatry and Mental health 7.0k
- Physiology 5.4k
- Biological Psychiatry 437
- Neurology 1.4k
- Geriatrics and Gerontology 427
Countries citing papers authored by David Ames
This map shows the geographic impact of David Ames's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Ames with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Ames more than expected).
Fields of papers citing papers by David Ames
This network shows the impact of papers produced by David Ames. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Ames. The network helps show where David Ames may publish in the future.
Co-authors
The 25 scholars most cited alongside David Ames, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 393 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Amyloid β deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer's disease: a prospective cohort study Hit paper breakdown → | 2013 | 1650 |
| 2 | Metal-Protein Attenuation With Iodochlorhydroxyquin (Clioquinol) Targeting Aβ Amyloid Deposition and Toxicity in Alzheimer Disease Hit paper breakdown → | 2003 | 812 |
| 3 | The Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging: methodology and baseline characteristics of 1112 individuals recruited for a longitudinal study of Alzheimer's disease Hit paper breakdown → | 2009 | 647 |
| 4 | Longitudinal assessment of Aβ and cognition in aging and Alzheimer disease Hit paper breakdown → | 2011 | 643 |
| 5 | Safety, efficacy, and biomarker findings of PBT2 in targeting Aβ as a modifying therapy for Alzheimer's disease: a phase IIa, double-blind, randomised, placebo-controlled trial Hit paper breakdown → | 2008 | 591 |
| 6 | 2003 | 349 | |
| 7 | Increased Risk of Cognitive Impairment in Patients With Diabetes Is Associated With Metformin Hit paper breakdown → | 2013 | 330 |
| 8 | 1990 | 269 | |
| 9 | 2017 | 225 | |
| 10 | 2012 | 201 | |
| 11 | 2012 | 197 | |
| 12 | 2012 | 191 | |
| 13 | 2008 | 190 | |
| 14 | 2013 | 181 | |
| 15 | 2015 | 180 | |
| 16 | 2010 | 179 | |
| 17 | 1998 | 176 | |
| 18 | 2002 | 173 | |
| 19 | Plasma Aβ42/40 ratio, p‐tau181, GFAP, and NfL across the Alzheimer's disease continuum: A cross‐sectional and longitudinal study in the AIBL cohort Hit paper breakdown → | 2022 | 170 |
| 20 | 2013 | 165 |
About David Ames
David Ames is a scholar working on Psychiatry and Mental health, Physiology, Cognitive Neuroscience, Radiology, Nuclear Medicine and Imaging and General Health Professions, having authored 393 papers that have together received 18.6k indexed citations. Recurring topics across this work include Dementia and Cognitive Impairment Research (190 papers), Alzheimer's disease research and treatments (66 papers), Functional Brain Connectivity Studies (21 papers), Advanced Neuroimaging Techniques and Applications (15 papers), Schizophrenia research and treatment (15 papers), Geriatric Care and Nursing Homes (13 papers), Nutritional Studies and Diet (12 papers) and Health disparities and outcomes (12 papers). The work is most often cited by research in Psychiatry and Mental health (7.0k citations), Physiology (5.4k citations), Biological Psychiatry (437 citations), Neurology (1.4k citations) and Geriatrics and Gerontology (427 citations). David Ames has collaborated with scholars based in Australia, United States and United Kingdom. Frequent co-authors include Colin L. Masters, Ralph N. Martins, Victor L. Villemagne, Kathryn A. Ellis, Paul Maruff, Cassandra Szoeke, Christopher C. Rowe, Olivier Salvado, Ashley I. Bush and Pierrick Bourgeat. Their work appears in journals such as Alzheimer s & Dementia, International Journal of Geriatric Psychiatry, Journal of Alzheimer s Disease, International Psychogeriatrics and The Medical Journal of Australia.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.